Hospital News and Research

RSS

Second US trial in HIV/AIDS lymphoma patients using Benitec’s ddRNAi technology

Benitec Limited (ASX:BLT), a company involved in RNA-based gene silencing for human therapeutics, announced that the City of Hope research hospital in Duarte, California is planning to initiate a second small Phase I/II study using Benitec’s DNA-directed RNA interference (ddRNAi) technology in lymphoma patients carrying the HIV virus. The aim of the study is to optimize the treatment by modifying a range of clinical parameters.

21 Mar 2011

NTSP Charitable Fund Board announces 2011 recipients of patient care grant funding opportunities

The North Texas Specialty Physicians (NTSP) Charitable Fund Board is pleased to announce the 2011 recipients of its patient care grant funding opportunities. The recipient organizations chosen serve the community and fit within the Charitable Fund's mission of "Driving innovations in the coordination and integration of safe and effective patient care in the North Texas Region."

21 Mar 2011

Girls with medical conditions causing short stature go undiagnosed

Primary care doctors are less likely to refer short girls than short boys for diagnostic testing that can reveal underlying medical reasons for their short stature, according to a new study of an urban pediatric population in Philadelphia. Girls with medical conditions causing their short stature may go undiagnosed, or may be diagnosed later than boys, limiting timely treatment.

21 Mar 2011

ViroPharma launches online community for teens and adults with hereditary angioedema

ViroPharma Incorporated today announced the launch of "HAE and Me," an online community that unites teens and adults with hereditary angioedema (HAE) through shared experiences to help them better manage their disease.

21 Mar 2011

Premier healthcare alliance named one of World's Most Ethical Companies for 2011

The Premier healthcare alliance has been named one of the Ethisphere Institute's 2011 World's Most Ethical Companies for the fourth year in a row. Ethisphere selected Premier from a record number of applicants across the globe.

21 Mar 2011

Study identifies gene linked to higher risk of multiple sclerosis in children

Canadians have one of the highest rates of Multiple Sclerosis (MS) in the world with approximately 1,000 new cases diagnosed each year. Primarily striking in adulthood, physicians and researchers with the Canadian Pediatric Demyelinating Diseases Network (CPDDN), a multi-institutional and multidisciplinary group, have found that MS is being increasingly diagnosed in children.

21 Mar 2011

March of Dimes awards Healthy Babies Healthy Business Seal of Approval to The Children's Hospital in Denver

The March of Dimes today announced it has awarded its first-ever Healthy Babies Healthy Business Seal of Approval, to The Children's Hospital in Denver. Children's becomes the first organization in Colorado - and the nation - to earn this new certification.

21 Mar 2011

Study unravels molecular mechanism of biomolecule RNA that plays dynamic regulatory role in protein selection

If a big bunch of your brain cells suddenly went rogue and decided to become fat cells, it could cloud your decision-making capacity a bit. Fortunately, early in an organism's development, cells make firm and more-or-less permanent decisions about whether they will live their lives as, say, skin cells, brain cells or, well, fat cells.

21 Mar 2011

SLEH treats irregular heartbeat with novel minimally invasive cold cryoballoon technology

A physician affiliated with Texas Heart® Institute (THI) at St. Luke's Episcopal Hospital (SLEH) is the first in Houston and among the first in the nation to treat patients for an irregular heartbeat with a new, minimally invasive cryoballoon technology that uses cold rather than heat to interrupt faulty electrical circuits in the heart.

21 Mar 2011

Intravenous Phenoxodiol-cisplatin combination well tolerated in platinum resistant ovarian cancer

Marshall Edwards, Inc., an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today the publication of results from a Phase II clinical trial of intravenous Phenoxodiol in combination with cisplatin in women with platinum-resistant ovarian cancer.

21 Mar 2011

Roundup: Kan., Calif. budget cuts; Texas NICU costs; Katrina trial; Medco CalPERS contract 'dumped'

This list of programs cut in the California state budget includes a 10 percent reduction in what the state pays for Medi-Cal patients at all long-term care facilities $172.3 million and a 10 percent reduction in what the state pays to physicians who see people on Medi-Cal.

21 Mar 2011

NasVax reports positive results from Phase 2a trial of oral immunotherapy for non-alcoholic steatohepatitis

NasVax announces the success of a Phase 2a clinical trial of a new oral immunotherapy for non-alcoholic steatohepatitis (NASH), an inflammatory disease associated with fatty liver disease and the metabolic syndrome.

21 Mar 2011

ACS announces definitive agreement to acquire CredenceHealth

Affiliated Computer Services, Inc. (ACS), A Xerox Company, today announced a definitive agreement to acquire CredenceHealth, Inc., creating a simple way for healthcare providers to use patient information to predict and prevent complications.

21 Mar 2011

Echo Therapeutics fiscal 2010 net loss decreases to $4.1 million

Echo Therapeutics, Inc., a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude™ SkinPrep System for transdermal drug delivery, today announced results for the year ended December 31, 2010.

21 Mar 2011

Innovative algorithm for AEDs distinguishes betweeen adult and child arrhythmias

Ventricular Fibrillation (VF) is a series of intense and disordered contractions of the ventricles (they are located in the lower part of the heart). In 40 % of respiratory arrests suffered outside a hospital, it was shown that the first cardiac rhythm corresponds to VF, and the only manner to combat it is with electric discharges provided by defibrillation. This

21 Mar 2011

FDA clears Insmed IND for ARIKACE Phase 3 clinical trial in nontuberculous mycobacteria lung infections

Insmed Incorporated, a biopharmaceutical company, announced today that the Company's Investigational New Drug Application (IND) to conduct a pivotal Phase 3 clinical trial of ARIKACE™ (liposomal amikacin for inhalation) in nontuberculous mycobacteria (NTM) lung infections has been cleared by the U.S. Food and Drug Administration (FDA).

21 Mar 2011

First clinical use of GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface on lower profile delivery system

W. L. Gore & Associates (Gore) today reported the first clinical use in the U.S. of the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface on a lower profile delivery system. The GORE VIABAHN Device is designed to percutaneously treat Superficial Femoral Artery (SFA) and iliac peripheral artery disease by relining the native vessel.

21 Mar 2011

Organic, non-toxic, biodegradable nanoparticle uses light and heat to treat cancer

A team of scientists from Princess Margaret Hospital have created an organic nanoparticle that is completely non-toxic, biodegradable and nimble in the way it uses light and heat to treat cancer and deliver drugs.

21 Mar 2011

Elevations in 5 amino acids may signal future disease risk

Measuring the levels of small molecules in the blood may be able to identify individuals at elevated risk of developing type 2 diabetes as much as a decade before symptoms of the disorder appear.

21 Mar 2011

New synchrotron-based imaging technique offers more detailed chemical images

With intensity a million times brighter than sunlight, a new synchrotron-based imaging technique offers high-resolution pictures of the molecular composition of tissues with unprecedented speed and quality. Carol Hirschmugl, a physicist at the University of Wisconsin-Milwaukee (UWM), led a team of researchers from UWM, the University of Illinois at Urbana-Champaign and University of Illinois at Chicago (UIC) to demonstrate these new capabilities.

21 Mar 2011

Hospital News and Research

Second US trial in HIV/AIDS lymphoma patients using Benitec’s ddRNAi technology

NTSP Charitable Fund Board announces 2011 recipients of patient care grant funding opportunities

Girls with medical conditions causing short stature go undiagnosed

ViroPharma launches online community for teens and adults with hereditary angioedema

Premier healthcare alliance named one of World's Most Ethical Companies for 2011

Study identifies gene linked to higher risk of multiple sclerosis in children

March of Dimes awards Healthy Babies Healthy Business Seal of Approval to The Children's Hospital in Denver

Study unravels molecular mechanism of biomolecule RNA that plays dynamic regulatory role in protein selection

SLEH treats irregular heartbeat with novel minimally invasive cold cryoballoon technology

Intravenous Phenoxodiol-cisplatin combination well tolerated in platinum resistant ovarian cancer

Roundup: Kan., Calif. budget cuts; Texas NICU costs; Katrina trial; Medco CalPERS contract 'dumped'

NasVax reports positive results from Phase 2a trial of oral immunotherapy for non-alcoholic steatohepatitis

ACS announces definitive agreement to acquire CredenceHealth

Echo Therapeutics fiscal 2010 net loss decreases to $4.1 million

Innovative algorithm for AEDs distinguishes betweeen adult and child arrhythmias

FDA clears Insmed IND for ARIKACE Phase 3 clinical trial in nontuberculous mycobacteria lung infections

First clinical use of GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface on lower profile delivery system

Organic, non-toxic, biodegradable nanoparticle uses light and heat to treat cancer

Elevations in 5 amino acids may signal future disease risk

New synchrotron-based imaging technique offers more detailed chemical images

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News